HEOR Impact Cases (Case Study) are exemplary illustrations of the transformative impact of HEOR that demonstrate how scientifically rigorous economic or cost evidence was used to inform a specific healthcare stakeholder decision or series of decisions, noting successes and lessons learned. The scope of HEOR Impact Cases may range from local (for example, from a local healthcare payer or provider organization serving a small jurisdiction or region) to national (for example, from a regulator or HTA body serving a country). HEOR Impact Cases must state which stakeholder(s) were directly involved in making the decision and how the evidence was used to answer an important issue or question they were facing. Stakeholder perspective(s) may include health technology assessor, payer, patient, healthcare provider, industry, investor, or government (including government-affiliated or government-commissioned organizations). Academic entities are also encouraged to submit HEOR Impact Cases  that showcase how their HEOR work directly impacted a stakeholder decision.

An important distinction between HEOR Impact Cases and Research submission categories is that HEOR Impact Cases must exemplify HEOR scientific evidence being directly applied to stakeholder decisions, i.e., they demonstrate the critical importance of “HEOR in action.” 

SUBMISSION INFORMATION

  • Submissions should entail use of HEOR at the population or group level (or consideration of its use).
  • We encourage submissions that involve the use (or consideration of the use) of real-world data.
  • Clinical cases which present the course of care, effectiveness, or adverse effects experienced by patient(s) are outside the scope of interest.
  • Submissions which refer to a named product or are promotional in nature will not be considered.
  • All impact case submissions and presentations must be in English.
  • ISPOR does not accept abstracts that have been previously presented at another meeting and/or previously published (either in print or online) by another Society or journal. HEOR Impact Cases presented at a previous ISPOR meeting is also not allowed. View ISPOR's abstract policy.
  • Accepted abstracts will be slotted as a podium (oral) or poster presentation. Your abstract's final presentation type will be decided upon by the program committee.
  • Submitters must agree to disclose AI-Assisted Content in the submission form. Failure to disclose submissions and/or accepted materials may result in its withdrawal from ISPOR. View ISPOR's AI policy.
  • Registration is required for all presenters. Expenses associated with submissions and presentations are the responsibility of the presenter.
  • Example of a case study abstract submission is available here.
  • Length of Abstract: 300 words

ISPOR Diversity Policy

ISPOR is strongly committed to diversity. The Society’s Strategic Plan and core values embrace excellence through encouragement and acceptance of diverse ideas, cultures, and disciplines. Research, HEOR Impact Cases, and Session submissions are encouraged from all stakeholders and are evaluated based on merit. ISPOR also aims to reflect the diversity of its membership in all endeavors and encourages consideration of diversity in abstract submissions. Diversity dimensions include (but not limited to) gender, career stage, ethnicity, race, education, sexual orientation, region/geographic location, disabilities, and religion. Additional information can be found at the Society’s Diversity Policy.

 


SUBMISSION INSTRUCTIONS

Below are instructions to assist with your HEOR Impact Case abstract submission. To access the submission portal, you will need to login using your ISPOR web credentials. If you do not have an ISPOR web profile, follow the "Create an Account" link on the ISPOR login page.

 If you have any questions concerning the submission process, please contact conferences@ispor.org or ispor@support.ctimeetingtech.com.

STEP 1: ACKNOWLEDGEMENTS & TITLE
When submitting your abstract, titles must be submitted in title case. Titles have a 225 maximum character limit. Your title should succinctly state the topic of the work. 

You must select each Acknowledgement checkbox and insert your title in order to save and proceed with your form.

STEPS 2 & 3: MAIN TOPIC/TAXONOMY, SUBTOPICS, AND LOCATION
When submitting your abstract, you must select at least one main topic/taxonomy area that best describes your abstract. This topic/taxonomy will also be used to assign the appropriate reviewer to your submission. If accepted, your abstract will also be categorized under this topic in the conference materials.

After selecting your main topic/taxonomy, you may then choose up to four subtopics. Expand each taxonomy area below to view the available subcategories.

Finally, select all geographic regions that apply to your impact case abstract in the Location section.

Clinical Outcomes

Comparative Effectiveness or Efficacy

Clinician Reported Outcomes

Relating Intermediate to Long-term Outcomes

Performance-based Outcomes

Clinician Outcomes Assessment

Economic Evaluation

Cost/Cost of Illness/Resource Use Studies

Budget Impact Analysis

Trial-based Economic Evaluation

Value of Information

Cost-comparison/effectiveness/utility/benefit Analysis

Thresholds & Opportunity Cost

Work & Home Productivity - Indirect Costs

Novel & Social Elements of Value

Epidemiology & Public Health

Safety & Pharmacoepidemiology

Prevalence, Incidence, & Disease Risk Factors

Public Health

Disease Classification & Coding

Health Policy & Regulatory

Approval & Labeling

Reimbursement & Access Policy

Public Spending & National Health Expenditures

Coverage with Evidence Development & Adaptive Pathways

Health Disparities & Equity

Pricing Policy & Schemes

Insurance Systems & National Health Care

Procurement Systems

Risk-sharing Approaches

Health Service Delivery & Process of Care

Hospital and Clinical Practices

Pharmacist Interventions and Practices

Telemedicine

Disease Management (including optimization studies)

Prescribing Behavior

Formulary Development

Quality of Care Measurement

Treatment Patterns and Guidelines

Health Technology Assessment

Systems & Structure

Decision & Deliberative Processes

Value Frameworks & Dossier Format

Medical Technologies

Devices

Digital Health

Diagnostics

Other

Methodological & Statistical Research

Artificial Intelligence, Machine Learning, Predictive Analytics

Confounding, Selection Bias Correction, Causal Inference

PRO & Related Methods

Survey Methods

Missing Data

Modeling, Simulation, Optimization

Preference Methods

Organizational Practices

Academic & Educational

Ethical

Geographic & Regional (not for epidemiology or treatment evaluation studies of population subgroups)

Industry

Best Research Practices


 

Patient-Centered Research

Adherence, Persistence, & Compliance

Health State Utilities

Patient Behavior and Incentives

Instrument Development, Validation, & Translation

Stated Preference & Patient Satisfaction

Patient-reported Outcomes & Quality of Life Outcomes

Patient Engagement

Real-World Data & Information Systems

Data Protection, Integrity, & Quality Assurance

Distributed Data & Research Networks

Health & Insurance Records Systems

Reproducibility & Replicability

Study Approaches

Clinical Trials (Traditional)

Prospective Observational Studies (including chart reviews and time and motion studies)

Surveys & Expert Panels

Literature Review & Synthesis

Meta-analysis & Indirect Comparisons

Pragmatic Trials & Large Simple Trials

Registries

Decision Modeling & Simulation

Retrospective Databases (EM&HR, Administrative Claims)

STEP 4:  SPECIFIC DISEASE & CONDITIONS/SPECIALIZED TREATMENT AREAS
In addition to your primary topic and subtopic selections, accepted abstracts can be grouped according to disease/treatment area. Please choose one option below to assist in assigning your abstract. 

Then, please select up to four additional disease & conditions/specialized treatment areas that best describe your abstract.

You can choose "No Additional Disease & Conditions/Specialized Treatment Areas" if no other disease/treatment area applies to your research.

Specific Diseases & Conditions

Cardiovascular Disorders (including MI, Stroke, Circulatory)

Diabetes/Endocrine/Metabolic Disorders (including obesity)

Gastrointestinal Disorders

Geriatrics

Infectious Disease (non-vaccine)

Injury & Trauma

Mental Health (including addiction)

Musculoskeletal Disorders (Arthritis, Bone Disorders, Osteoporosis, Other Musculoskeletal)

Neurological Disorders

Oncology

Pediatrics

Rare & Orphan Diseases

Reproductive & Sexual Health

Respiratory-Related Disorders (Allergy, Asthma, Smoking, Other Respiratory)

Sensory System Disorders (Ear, Eye, Dental, Skin)

Systemic Disorders/Conditions (Anesthesia, Auto-Immune Disorders (n.e.c.), Hematological Disorders (non-oncologic), Pain)

Urinary/Kidney Disorders

Specialized Treatment Areas

Alternative Medicine

Biologics & Biosimilars

Genetic, Regenerative & Curative Therapies

Multiple/Other Specialized Treatments

Generics

Nutrition

Personalized & Precision Medicine

Surgery

Vaccines

Veterinary Medicine

STEPS 5 & 6: SUBMITTER AND AUTHOR

Include submitter information and all authors that are affiliated with your impact case abstract. If accepted, the submitter information will not be published in conference materials.

Under the Author step, the submitter's information will pre-populate, except for their Degree and Work Environment fields. Please click on the Edit link to enter that information so you can complete your submission.

To add other authors, please click on the "Add Author" link and follow instructions to search for additional author(s). Each author will need an ISPOR profile in order to be added to your abstract. If you cannot find your author using the search fields, please use the create a new ISPOR profile link in the submission form. The ISPOR profile form will open in a new window/tab. Complete the information and close the window/tab to return to your submission and search again.

You will have to assign one Presenting Author upon submission. If multiple perspectives are being included, then coauthors representing each perspective are expected. Please note: you will have the opportunity to update your presenting author closer to the conference. 

All accepted presenting authors must register for the meeting and are responsible for their meeting registration fees, unless otherwise notified in writing by ISPOR. 

STEP 7: ABSTRACT TEXT 
Follow the “Enter Abstract Text” link to add your abstract text into the system. Abstract has 100 minimum/309 maximum word count, including headers mentioned below. Please enter your abstract text only into each text field, do not include title, authors, or headers.

  • Problem Statement: Consists of a brief statement of the healthcare decision addressed by the work.
  • Description: Includes an explanation of the work, starting with what led to the need for the healthcare decision, how it was evaluated, how specific HEOR data were used to evaluate the issue and/or inform the decision, and what decision was ultimately made. Decisions that were not successfully made through the work may also be submitted, though an explanation as to why the decision could not be made should be provided.
  • Lessons Learned: Should state what lessons were learned from the work.
  • Stakeholder Perspective: Should specify what perspective is this being told from (payer, patient, provider, industry, or government (including government-affiliated or government-commissioned organizations).

STEP 8: REVIEW MY WORK
Review your submission carefully and fix any incomplete items. If your submission is complete, you will have the option to send a confirmation of your submission via email or obtain a printer-friendly version of your submission.

When you return to your ISPOR 2025 Submission Portal, your submission will be labeled "Complete" (green) or "Incomplete" (yellow). Complete submissions will be submitted for review after the submission deadline.

Submitters can return to their submission and edit at any time prior to the submission deadline.


CRITERIA FOR EVALUATION OF CASE STUDY ABSTRACTS:

Please consider the updated submission criteria when submitting your proposal:

Quality of content

  • Submission demonstrates the impact of HEOR evidence as a critical tool to understand and/or address a clearly stated healthcare problem, question, or issue.
  • Submission specifies stakeholder type(s) to which the problem applies.
  • Content demonstrates application of HEOR science with methods, results, and data sources stated.
  • Articulation of lessons learned.
  • Topic is timely.
  • Content is free from bias (i.e., it  does not promote a product, service, or organization). Abstracts deemed to be promotional will be excluded from consideration).

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×